Literature DB >> 9355767

ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2.

G Jedlitschky1, I Leier, U Buchholz, J Hummel-Eisenbeiss, B Burchell, D Keppler.   

Abstract

Bilirubin is secreted from the liver into bile mainly as monoglucuronosyl and bisglucuronosyl conjugates. We demonstrate for the first time that ATP-dependent transport of both bilirubin glucuronides is mediated by the multidrug resistance protein (MRP1) as well as by the distinct canalicular (apical) isoform MRP2, also termed cMRP or cMOAT (canalicular multispecific organic anion transporter). In membrane vesicles from MRP1-transfected HeLa cells mono[3H]glucuronosylbilirubin and bis[3H]glucuronosylbilirubin (each at 0.5 microM) were transported with rates of 5.3 and 3.1 pmol/min per mg of protein respectively. Rat hepatocyte canalicular membrane vesicles, which contain Mrp2 (the rat equivalent of MRP2), transported mono[3H]glucuronosylbilirubin and bis[3H]glucuronosylbilirubin at rates of 8.9 and 8.5 pmol/min per mg of protein, whereas membrane vesicles from mutant liver lacking Mrp2 showed no transport of the conjugates. In membrane vesicles from human hepatoma Hep G2 cells, which predominantly expressed MRP2, transport rates were 8.3 and 4.4 pmol/min per mg of protein for monoglucuronosylbilirubin and bisglucuronosylbilirubin respectively. ATP-dependent transport of the glutathione S-conjugate -3H-leukotriene C4, an established high-affinity substrate for MRP1 and MRP2, was inhibited by both bilirubin glucuronides with IC50 values between 0.10 and 0.75 microM. The ratios of leukotriene C4 transport and bilirubin glucuronide transport, determined in the same membrane vesicle preparation, indicated substrate specificity differences between MRP1 and MRP2 with a preference of MRP2 for the glucuronides.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9355767      PMCID: PMC1218795          DOI: 10.1042/bj3270305

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

Review 1.  Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport.

Authors:  R P Oude Elferink; D K Meijer; F Kuipers; P L Jansen; A K Groen; G M Groothuis
Journal:  Biochim Biophys Acta       Date:  1995-07-17

Review 2.  Specificity of human UDP-glucuronosyltransferases and xenobiotic glucuronidation.

Authors:  B Burchell; C H Brierley; D Rance
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

3.  ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein.

Authors:  G Jedlitschky; I Leier; U Buchholz; M Center; D Keppler
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

4.  Detection of the M(r) 190,000 multidrug resistance protein, MRP, with monoclonal antibodies.

Authors:  D R Hipfner; S D Gauldie; R G Deeley; S P Cole
Journal:  Cancer Res       Date:  1994-11-15       Impact factor: 12.701

5.  Analysis of MRP gene expression and function in HL60 cells isolated for resistance to adriamycin.

Authors:  N Krishnamachary; L Ma; L Zheng; A R Safa; M S Center
Journal:  Oncol Res       Date:  1994       Impact factor: 5.574

6.  The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates.

Authors:  I Leier; G Jedlitschky; U Buchholz; S P Cole; R G Deeley; D Keppler
Journal:  J Biol Chem       Date:  1994-11-11       Impact factor: 5.157

7.  Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport.

Authors:  M Müller; C Meijer; G J Zaman; P Borst; R J Scheper; N H Mulder; E G de Vries; P L Jansen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

8.  Cholestasis caused by inhibition of the adenosine triphosphate-dependent bile salt transport in rat liver.

Authors:  M Böhme; M Müller; I Leier; G Jedlitschky; D Keppler
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

9.  Noninvasive assessment of hepatobiliary and renal elimination of cysteinyl leukotrienes by positron emission tomography.

Authors:  A Guhlmann; K Krauss; F Oberdorfer; T Siegel; P H Scheuber; J Müller; B Csuk-Glänzer; S Ziegler; H Ostertag; D Keppler
Journal:  Hepatology       Date:  1995-06       Impact factor: 17.425

10.  Expression of the multidrug resistance-associated protein (MRP) gene in human lung tumours and normal tissue as determined by in situ hybridisation.

Authors:  G A Thomas; M A Barrand; S Stewart; P H Rabbitts; E D Williams; P R Twentyman
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

View more
  47 in total

Review 1.  The molecular genetics of familial intrahepatic cholestasis.

Authors:  P L Jansen; M Müller
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

2.  Genome-wide association of serum bilirubin levels in Korean population.

Authors:  Tae-Wook Kang; Hee-Jin Kim; Hyoungseok Ju; Jeong-Hwan Kim; Yeo-Jin Jeon; Han-Chul Lee; Ka-Kyung Kim; Jong-Won Kim; Siwoo Lee; Jong Yeol Kim; Seon-Young Kim; Yong Sung Kim
Journal:  Hum Mol Genet       Date:  2010-07-16       Impact factor: 6.150

3.  Promoter polymorphism of MRP1 associated with reduced survival in hepatocellular carcinoma.

Authors:  Jing Zhao; Bing-Yun Yu; Dao-Yuan Wang; Jin-E Yang
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 4.  Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.

Authors:  Xianhua Cao; Seth T Gibbs; Lanyan Fang; Heather A Miller; Christopher P Landowski; Ho-Chul Shin; Hans Lennernas; Yanqiang Zhong; Gordon L Amidon; Lawrence X Yu; Duxin Sun
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

5.  Drug- and Drug Abuse-Associated Hyperbilirubinemia: Experience With Atazanavir.

Authors:  Jayanta Roy-Chowdhury; Namita Roy-Chowdhury; Irving Listowsky; Allan W Wolkoff
Journal:  Clin Pharmacol Drug Dev       Date:  2017-03

6.  Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues.

Authors:  Liqi Lai; Theresa M C Tan
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

7.  Phase I and II metabolism and MRP2-mediated export of bosentan in a MDCKII-OATP1B1-CYP3A4-UGT1A1-MRP2 quadruple-transfected cell line.

Authors:  C Fahrmayr; J König; D Auge; M Mieth; K Münch; J Segrestaa; T Pfeifer; A Treiber; Mf Fromm
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

Review 8.  Excretion of biliary compounds during intrauterine life.

Authors:  Rocio I R Macias; Jose J G Marin; Maria A Serrano
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

9.  The human multidrug-resistance-associated protein MRP1 mediates ATP-dependent transport of unconjugated bilirubin.

Authors:  Igino Rigato; Lorella Pascolo; Cristina Fernetti; J Donald Ostrow; Claudio Tiribelli
Journal:  Biochem J       Date:  2004-10-15       Impact factor: 3.857

10.  Are MDCK cells transfected with the human MRP2 gene a good model of the human intestinal mucosa?

Authors:  Fuxing Tang; Kazutoshi Horie; Ronald T Borchardt
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.